Form 8-K - Current report:
SEC Accession No. 0001013762-25-001245
Filing Date
2025-03-24
Accepted
2025-03-24 08:30:36
Documents
14
Period of Report
2025-03-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0235272-8k_aditxt.htm   iXBRL 8-K 33820
2 TRANSCRIPT OF CORPORATE UPDATE- MARCH 21, 2025 ea023527201ex99-1_aditxt.htm EX-99.1 60154
  Complete submission text file 0001013762-25-001245.txt   287467

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20250321.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20250321_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20250321_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0235272-8k_aditxt_htm.xml XML 3786
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 25762330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)